澳大利亚维多利亚州的一项新研究揭示，2013年至2023年间大麻相关医院入院率增长了49%，在这十年间共录得39,565例相关入院病例1。精神类疾病是最主要的诱因，占大麻相关入院比例的40.1%，其中包括精神分裂症等严重精神健康问题1。相比之下，因大麻中毒入院的患者不到总数的12%1。
研究数据显示，住院患者中68%的病程超过24小时，平均住院时间为一周，且超过1,500名患者需要入住重症监护室1。虽然15至24岁的男性仍构成最大的住院群体，但十年间年轻女性和65岁以上老年人的入院增幅最为显著1。研究人员指出，高效力大麻制品的普遍使用可能是推高住院率的因素之一，某些处方产品的四氢大麻酚含量甚至高达88%1。此外，2020年至2021年期间新冠疫情期间的入院病例达到峰值1。在全国范围内，大麻已成为导致医院入院的主要非法药物，其影响力超过非法阿片类药物1。
A new study examining cannabis-related hospital admissions in Victoria, Australia, reveals a significant increase over the past ten years.1 Between 2013 and 2023, the state recorded 39,565 cannabis-related hospital admissions, with the overall rate climbing 49% during this period.1 Mental health conditions, particularly psychosis and schizophrenia, emerged as the primary driver, accounting for 40.1% of all cannabis-related hospitalizations, while poisoning cases represented less than 12% of admissions.1
The research indicates that certain demographic groups experienced the most dramatic increases, even as 15- to 24-year-old males remained the largest hospitalized population.1 Young women and adults over 65 saw the steepest rises in admission rates across the decade.1 The majority of patients—68%—required hospital stays exceeding 24 hours, with an average length of stay of one week, and more than 1,500 individuals were admitted to intensive care units.1 Admissions peaked during the 2020-2021 COVID-19 pandemic period.1
Several factors have been linked to the surge in hospitalizations.1 The increasing potency of cannabis products represents a significant concern, with some prescription-grade formulations containing THC levels as high as 88%.1 Researchers also point to shifting social attitudes toward cannabis and expanded medical prescribing as contributing factors.1 Notably, cannabis has become Australia's leading cause of hospital admission among illegal drugs nationally, surpassing illegal opioids.1
评论
还没有评论，欢迎留下第一条。